Image
Loading
Image
3 noiembrie, 2024

The prognostic and predictive value of Oncotype DX® in ER+/HER2-/pT2N0, cM0 Breast Cancer Patients

Natsiopoulos I., Iosifidou R., Markopoulos C., Xepapadakis G., Tsoulos N., Giannoulakis S., Kapetsis G., Psyrri A., Saridaki Z., Venizelos V., Nikolaidi A., Savvidou A., Mpoutis A., Mpoukovinas I., Kotsakis A., Christopoulou A., Saloustros E., Mavroudis D., Aggelaki S., Assi A., Tzanninis D., Grosomanidis D., Fountzilas E., Lala E., Ignatiadou E., Skondra M., Zagouri F., Koumarianou A., Kosmidis P., Douvetzemis S., Papazisis K., Anastasakou K., Pavlidou F., Kampletsas E., Poulakaki F., Simpilidis G., Triantafillidou S., Stathoulopoulou M.